Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.

IF 1.8 4区 医学 Q3 INFECTIOUS DISEASES
Jianwei Zhang, Jinlong Ding, Xinqi Ma
{"title":"Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.","authors":"Jianwei Zhang, Jinlong Ding, Xinqi Ma","doi":"10.1016/j.diagmicrobio.2026.117747","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.</p><p><strong>Methods: </strong>This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.</p><p><strong>Results: </strong>HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).</p><p><strong>Conclusions: </strong>HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.</p><p><strong>Importance: </strong>The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117747"},"PeriodicalIF":1.8000,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.diagmicrobio.2026.117747","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.

Methods: This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.

Results: HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).

Conclusions: HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.

Importance: The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.

绍兴市2019冠状病毒病大流行后呼吸道感染儿童人腺病毒感染流行情况回顾性分析
目的:在2019冠状病毒病(COVID-19)防控过渡期间,中国各地区的人腺病毒(hav)活性发生了变化。我们研究了绍兴市急性呼吸道感染(ARIs)住院儿童的hav阳性是否从2022年到2024年有所增加,并描述了其按年龄、季节和临床表现的分布。方法:对9714例住院儿童进行单中心回顾性研究。结果:hav检出461例(4.75%)。报告的年增长率从2022年的0.85%上升到2023年的2.07%和2024年的8.99%。结论:2022 - 2024年绍兴市接受检测的儿科住院患者hav阳性率呈上升趋势,且大年龄组和夏季合并阳性率较高。这些发现支持继续进行医院监测,包括分子分型以调查循环型。重要性:hav的传播途径与COVID-19相似,提示非药物干预对两者的影响可能是等效的。本研究旨在分析2022 - 2024年绍兴市儿童hav感染的流行病学特征。本研究探讨COVID-19和非药物干预对hav流行的影响,为疾病治疗和感染预防提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
3.40%
发文量
149
审稿时长
56 days
期刊介绍: Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书